PureHealth in the Middle East is set to acquire a 60% stake in Hellenic Healthcare Group (HHG) in a $2.3bn deal.

Currently, HHG is 90% owned by CVC Capital Partners VI and the remaining 10% is held by HHG's founder.

CVC will now retain a 35% share, and the founder will maintain the 5% stake in the company.

HHG operates a network of ten hospitals and 16 diagnostic centres across Greece and Cyprus, with a capacity exceeding 1,600 beds. It caters to around 1.4 million patients each year, employing more than 6,700 healthcare professionals.

The group provides advanced medical services and specialises in medical fields such as cardiology, oncology and neurosurgery.

Additionally, HHG offers homecare services and IVF treatments, with more than 6,000 cycles performed every year.

The acquisition is consistent with PureHealth's strategy for expansion, utilising its scale and resources to strengthen HHG's presence in Greece.

By prioritising operational efficiency and improved patient outcomes, PureHealth seeks to establish new standards for healthcare delivery throughout its international network.

PureHealth group CEO Shaista Asif said: "This move aligns with our vision of becoming a global leader in healthcare, with more than 50% of our revenues originating outside the GCC."

Upon completion of the deal, CVC and HHG Management will hold a 40% stake in HHG, remaining as partners.

This partnership will enable HHG to leverage the expertise, resources, and global networks of both PureHealth and CVC.

CVC Greece partner and head Alex Fotakidis said: "We have a very strong management team who have built a quality organisation and we, together with our partners are looking forward to expanding the HHG platform to deliver better value to our patients."

The finalisation of the acquisition is contingent on receiving regulatory approvals and fulfilling customary closing conditions.